Browsing by Yonsei Author : Kim, Joo Hang

Name:
Kim, Joo Hang [김주항]
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Y-HRN :
(Yonsei Health Research Network)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleJournal Title
2017A randomized; phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) (vol 8; pg 15943; 2017) ONCOTARGET
2017Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.JOURNAL OF CLINICAL ONCOLOGY
2016Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer CANCER RESEARCH AND TREATMENT
2016Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2016EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines MOLECULAR CANCER THERAPEUTICS
2016Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cellsAPOPTOSIS
2016Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer. BMC CANCER
2016Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapyPHARMACOGENETICS AND GENOMICS
2015Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neckCLINICAL CANCER RESEARCH
2015Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cellsCELLULAR SIGNALLING
2015Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrestCELLULAR SIGNALLING
2015Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. ONCOTARGET
2015Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma MOLECULAR CANCER THERAPEUTICS
2015An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerEUROPEAN JOURNAL OF CANCER
2015LAMC2 enhances the metastatic potential of lung adenocarcinomaCELL DEATH AND DIFFERENTIATION
2015Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma ONCOTARGET
2015Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication PLOS ONE
2015The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancerLUNG CANCER
2014Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virusBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2014Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinomaLUNG CANCER
2014A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaLUNG CANCER
2014Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitorsTHORACIC CANCER
2014Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers GENOME MEDICINE
2014Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.LANCET
2014Clinical Outcome According to the Level of Preexisting Epidermal Growth Factor Receptor T790M Mutation in Patients With Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor MutationsCANCER
2014Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsLUNG CANCER
2013TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complexCELLULAR SIGNALLING
2013A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesANNALS OF ONCOLOGY
2013Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNACANCER GENE THERAPY
2013c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5CANCER GENE THERAPY
2013Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY
2013Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment: Inhibition of apoptosis by caspase degradation.CELLULAR SIGNALLING
2013Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors SUPPORTIVE CARE IN CANCER
2013Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung YONSEI MEDICAL JOURNAL
2013Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer YONSEI MEDICAL JOURNAL
2013Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK ActivationMOLECULAR CANCER THERAPEUTICS
2013S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial BMC CANCER
2013Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancerBREAST
2013The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagyINTERNATIONAL JOURNAL OF ONCOLOGY
2013The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma YONSEI MEDICAL JOURNAL
2013Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerLUNG CANCER
2013The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma ANNALS OF ONCOLOGY
2013Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
2013A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)LUNG CANCER
2012Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer BMC CANCER
2012Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. CANCER
2012HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL.CELLULAR SIGNALLING
2012High EGFR gene copy number and skin rash as predictive markers for EGFR tyrosine kinase inhibitors in patients with advanced squamous cell lung carcinoma. CLINICAL CANCER RESEARCH
2012Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy PLOS ONE

Browse

Links